H Thomasen1, K-P Steuhl, D Meller. 1. Zentrum für Augenheilkunde, Klinik für Erkrankungen des vorderen Augenabschnitts, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland.
Abstract
PURPOSE: The use of cryopreserved amniotic membranes for the treatment of diseases and injuries of the surface of the eye is an established procedure in ophthalmological surgery. Before clinical use of cryopreserved amniotic membranes (AM) a careful testing for microbial contamination is essential to ensure a safe application. In this study the use of the BacT/Alert® test system was evaluated for screening of microbial growth in AMs. MATERIALS AND METHODS: Minced fresh and cryopreserved AMs (approximately 5 × 5 cm in size) were injected with 10 ml of balanced salt solution in separate culture media test bottles and 10 ml of cryopreservation medium bacterial and fungal test strains according to European Union (EU) regulations were applied to test the performance of the system. Approximately 10-100 colony forming units were applied on the samples prior to injection in the corresponding test bottles. Bottles were incubated at 37 °C for 7 days. Positive controls contained only balanced salt solution and the test strains while negative controls contained the test material without microbial test strains. RESULTS: Growth of the test strains was detected in all inoculated samples from non-processed and cryopreserved AM within the 7-day incubation period. In samples of the cryopreservation medium only growth of the fungus Candida albicans could be detected. CONCLUSIONS: The automated BacT/Alert test system is suitable for testing of microbial safety of amniotic membranes but not for testing the cryopreservation medium in clinical practice according to EU regulations.
PURPOSE: The use of cryopreserved amniotic membranes for the treatment of diseases and injuries of the surface of the eye is an established procedure in ophthalmological surgery. Before clinical use of cryopreserved amniotic membranes (AM) a careful testing for microbial contamination is essential to ensure a safe application. In this study the use of the BacT/Alert® test system was evaluated for screening of microbial growth in AMs. MATERIALS AND METHODS: Minced fresh and cryopreserved AMs (approximately 5 × 5 cm in size) were injected with 10 ml of balanced salt solution in separate culture media test bottles and 10 ml of cryopreservation medium bacterial and fungal test strains according to European Union (EU) regulations were applied to test the performance of the system. Approximately 10-100 colony forming units were applied on the samples prior to injection in the corresponding test bottles. Bottles were incubated at 37 °C for 7 days. Positive controls contained only balanced salt solution and the test strains while negative controls contained the test material without microbial test strains. RESULTS: Growth of the test strains was detected in all inoculated samples from non-processed and cryopreserved AM within the 7-day incubation period. In samples of the cryopreservation medium only growth of the fungus Candida albicans could be detected. CONCLUSIONS: The automated BacT/Alert test system is suitable for testing of microbial safety of amniotic membranes but not for testing the cryopreservation medium in clinical practice according to EU regulations.
Authors: A Pruss; B Baumann; M Seibold; M Kao; K Tintelnot; R von Versen; H Radtke; T Dörner; G Pauli; U B Göbel Journal: Biologicals Date: 2001-06 Impact factor: 1.856
Authors: Axel Pruss; Carsten Perka; Petra Degenhardt; Ute Maronna; Karin Büttner-Janz; Bodo Paul; Klaus Müller; Christoph Klumpp; Johannes C Bruck; Rüdiger Von Versen Journal: Cell Tissue Bank Date: 2002 Impact factor: 1.522
Authors: M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García Journal: Antimicrob Agents Chemother Date: 1992-04 Impact factor: 5.191
Authors: E Plantamura; G Huyghe; B Panterne; N Delesalle; A Thépot; M E Reverdy; O Damour; Céline Auxenfans Journal: Cell Tissue Bank Date: 2011-12-09 Impact factor: 1.522
Authors: C P McDonald; A Rogers; M Cox; R Smith; A Roy; S Robbins; S Hartley; J A J Barbara; S Rothenberg; L Stutzman; G Widders Journal: Transfus Med Date: 2002-10 Impact factor: 2.019